Fumito Abe
Impact in
-
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Dermatology top 10%
- Cutaneous lymphoproliferative disorders research
Papers in
-
- Renal Diseases and Glomerulopathies 5
-
- T-cell and Retrovirus Studies 5
- Co-authors
- Naoto Takahashi (19 shared papers)Sho Ikeda (9 shared papers)Akihiro Kitadate (10 shared papers)Hiroyuki Tagawa (9 shared papers)Hideki Wakui (11 shared papers)Atsushi Komatsuda (10 shared papers)Masaya Masayoshi Saito (9 shared papers)Makoto Sugaya (3 shared papers)
- Journals
- Cancer Science (3 papers)Oncotarget (2 papers)Blood (2 papers)Blood Advances (1 paper)Haematologica (1 paper)
- Partner nations
- Japan
In The Last Decade
Fumito Abe
20 papers receiving 290 citations
Peers
Comparison fields: 5 of 42
- Cancer Research 73
- Dermatology 43
- Hematology 45
- Nephrology 23
- Immunology 60
Countries citing papers authored by Fumito Abe
This map shows the geographic impact of Fumito Abe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumito Abe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumito Abe more than expected).
Fields of papers citing papers by Fumito Abe
This network shows the impact of papers produced by Fumito Abe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumito Abe. The network helps show where Fumito Abe may publish in the future.
Co-authors
The 25 scholars most cited alongside Fumito Abe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 59 | |
| 2 | 2020 | 51 | |
| 3 | 2016 | 30 | |
| 4 | 2017 | 30 | |
| 5 | 2016 | 25 | |
| 6 | 2017 | 20 | |
| 7 | 2019 | 15 | |
| 8 | 2022 | 13 | |
| 9 | 2022 | 12 | |
| 10 | 2017 | 7 | |
| 11 | 2020 | 7 | |
| 12 | 2022 | 6 | |
| 13 | 2020 | 5 | |
| 14 | 2019 | 4 | |
| 15 | 2023 | 3 | |
| 16 | 2021 | 2 | |
| 17 | 2023 | 1 | |
| 18 | 2022 | 1 | |
| 19 | 2016 | 1 | |
| 20 | 2016 | 1 |
About Fumito Abe
Fumito Abe is a scholar working on Nephrology, Immunology, Dermatology, Hematology and Cancer Research, having authored 23 papers that have together received 293 indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (5 papers), Cutaneous lymphoproliferative disorders research (5 papers), T-cell and Retrovirus Studies (5 papers), Histone Deacetylase Inhibitors Research (4 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (3 papers), Vasculitis and related conditions (2 papers), Cancer-related molecular mechanisms research (2 papers) and Multiple Myeloma Research and Treatments (2 papers). The work is most often cited by research in Cancer Research (73 citations), Dermatology (43 citations), Hematology (45 citations), Nephrology (23 citations) and Immunology (60 citations). Fumito Abe has collaborated with scholars based in Japan. Frequent co-authors include Naoto Takahashi, Sho Ikeda, Akihiro Kitadate, Hiroyuki Tagawa, Hideki Wakui, Atsushi Komatsuda, Masaya Masayoshi Saito, Makoto Sugaya, Mizuho Nara and Tomomitsu Miyagaki. Their work appears in journals such as Cancer Science, Oncotarget, Blood, Blood Advances and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.